Skip to content

Prospective Case Series of Acute Complex Wounds Treated With Glyaderm

Prospective Case Series of Acute Complex Wounds Treated With Glyaderm

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20860
Enrollment
28
Registered
2021-08-13
Start date
2021-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute deep dermal to full thickness skin and soft tissue defect(s) that will either not heal or take weeks to heal without grafting or (free) flap surgery.

Interventions

Surgical application of Glyaderm and a split thickness skin graft in acute deep dermal to full thickness skin and soft tissue defects.

Sponsors

Not applicable.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Acute deep dermal to full thickness skin and soft tissue defect(s) that will either not heal or take weeks to heal without grafting or (free) flap surgery*. 2. Age =18 years old 3. Written informed consent *These include, but are not limited to, donor sites of (free) flap harvest, defects after oncological resection, necrotising fasciitis and degloving injury.

Exclusion criteria

Exclusion criteria: 1. Active infection 2. Severe cognitive dysfunction or psychiatric disorders in patient history 3. Skin defects due to burns.

Design outcomes

Primary

MeasureTime frame
The main study endpoint is graft take in the grafted wound site(s) in a total follow-up of 12 weeks.

Secondary

MeasureTime frame
Wound epithelialisation 5-7 days after split skin graft placement. Day of wound closure (>95% epithelialisation). Incidence of complications: hematoma, graft loss, graft shift, post-operative bleeding, regrafting and wound infection. Surgical and patient characteristics (timing (time in days between trauma and first reconstructive surgery); number of surgical debridements before reconstructive surgery, surgery duration, total body surface area (%) covered, length of hospital stay) Subjective assessment of the scar after 12 weeks.

Contacts

Public ContactElleke Munk

Radboudumc

elleke.munk@radboudumc.nl-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)